Aging
Navigate
Editorial|Volume 11, Issue 13|pp 4305—4307

A preclinical model for phenogroup 3 HFpEF

Keyvan Yousefi1,2, Julian C. Dunkley3, Lina A. Shehadeh2,3,4,5
  • 1Department of Molecular and Cellular Pharmacology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 2Interdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 3Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 4Vascular Biology Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 5Peggy and Harold Katz Family Drug Discovery Center, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
Received: June 21, 2019Accepted: June 23, 2019Published: July 15, 2019

Yousefi et al. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.